Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS）

NCT05087706 · clinicaltrials.gov ↗

UNKNOWN

Status

182

Enrollment

OTHER

Sponsor class

Conditions

Salivary Gland Neoplasms

Interventions

DRUG: Pyrotinib
DRUG: Bicalutamide
DRUG: Leuprorelin

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University